AHR and chronic kidney disease: In patients with CKD on hemodialysis, a 3-month oral supplementation with the AHR ligand curcumin displays anti-inflammatory effects by significantly decreasing plasma levels of hsCRP and NF-κB expression in leukocytes [169].